1. Home
  2. /
  3. Publications

Publications


June 2019

Community Oncology Alliance Announces ‘OCM 2.0’ Proposal, an Ambitious Reform Model to Improve Cancer Care and Reduce Costs

PTAC Application Demonstrates Community Oncology’s Continued Leadership in Providing Solutions to Cancer Care Cost and Quality Challenges The Community Oncology Alliance (COA) has submitted an innovative and ambitious reform model to improve quality, reduce costs, and provide important additional cancer care services to patients, caregivers, and survivors. Known as the “OCM 2.0”, the detailed

Download (PDF) Read Full
April 2019

Cost Differential of Immuno-Oncology Therapy Delivered at Community Versus Hospital Clinics

Oncology treatment advances continue to evolve at a rapid pace, with immuno-oncology (I-O) therapy at the forefront given its efficacy and tolerability across different tumor types. The last few years have seen fast-track approvals, promising clinical responses, and significant investment from both pharmaceutical companies and venture capital firms. Various forms of I-O therapy exist,

Download (PDF) Read Full
April 2019

Pharmacy Benefit Manager Horror Stories — Part V

The Pharmacy Benefit Manager (PBM) industry lobby claims that it successfully achieves drastic price reductions on medications. They say this comes from PBMs negotiating with competing drug companies and by “encouraging consumers to use the most cost-effective drugs.” Setting aside clear evidence that secretive PBM rebates and fees are actually driving drug prices higher,

Download (PDF) Read Full
February 2019

Community Oncology Alliance: 2018 Year in Review

Introduction In 2018, the assault on patient access to local and affordable cancer care provided by community oncologists, upon which over half of all Americans rely, continued. The work of the Community Oncology Alliance (COA) repelled, repealed, or slowed down a record number of significant challenges to patients and practices, including proposed cuts to

Download (PDF) Read Full
January 2019

COA comment letter on CMS plans to “modernize” the Part D program and Medicare Advantage (MA) plans

Submitted electronically to: http://www.regulations.gov The Honorable Seema Verma, Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-4180-P P.O. Box 8013 Baltimore, MD 21244-8013 Re: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out of Pocket Expenses; CMS-4180-P Dear Administrator Verma: On behalf of the

Download (PDF) Read Full
December 2018

The Myth of Perverse Physician Incentives: Examining Research and Accusations in the Medicare Part B ASP Reimbursement System for Oncology

A frequent accusation aimed at physicians who prescribe and administer medications within the Medicare Part B system is that they are motivated by a perverse incentive of higher reimbursement to prescribe expensive drugs. For oncologists, who utilize potentially life-saving, but increasingly very expensive drugs in treating some of the nation’s sickest patients, this is a

Download (PDF) Read Full
December 2018

COA Comments Objecting to CVS-Aetna Merger

Peter Mucchetti, Esq. Peter.J.Mucchetti@usdoj.gov Antitrust.atr@usdoj.gov Chief, Healthcare and Consumer Products Section, Antitrust Division, Department of Justice 450 Fifth Street NW, Suite 4100 Washington, DC 20530 RE: United States of America v. CVS Health Corporation and Aetna Inc. Dkt. No.: 1:18-cv-02340 Dear Mr. Mucchetti: The Community Oncology Alliance (“COA”) submits this letter on behalf of

Download (PDF) Read Full
November 2018

COA Comments on Revisions to USP General Chapter 797 Pharmaceutical Compounding – Sterile Preparations

Submitted electronically to: CompoundingSL@usp.org Ronald T. Piervincenzi, Ph.D. Chief Executive Officer U.S. Pharmacopeial Convention 12601 Twinbrook Parkway Rockville, MD 20852-1790 Re: Comments to Proposed Revisions to USP General Chapter <797> Pharmaceutical Compounding – Sterile Preparations Dear Dr. Piervincenzi, On behalf of the Board of Directors of the Community Oncology Alliance (COA), we thank you

Download (PDF) Read Full
October 2018

Cost Differences Associated With Oncology Care Delivered in a Community Setting Versus a Hospital Setting

Florida Cancer Specialists and Research Institute, Gainesville; Xcenda, Palm Harbor, FL; and IntrinsiQ, Fresno, AZ Corresponding author: Lucio Gordan, MD, Florida Cancer Specialists and Research Institute, Division of Quality and Informatics, 6420 W Newberry Rd, Suite 100, Gainesville, FL 32605; e-mail: lgordan@flcancer.com. Disclosures provided by the authors are available with this article at jop.ascopubs.org.

Download (PDF) Read Full
September 2018

COA Submits Formal Comments on HOPPS Proposed Rule

Submitted electronically to: http://www.regulations.gov The Honorable Seema Verma, Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-1695-P P.O. Box 8016 Baltimore, MD 21244-8013 Re: Medicare Program: Proposed Changes to Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs; Requests for Information on Promoting

Download (PDF) Read Full